Aktie A089140 NEXTURNBIOSCIENCE CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NEXTURNBIOSCIENCE Co., Ltd.

Aktien

A089140

KR7089140008

A089140

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 20.05.2024 		% 5 Tage % 1. Jan.
4 025 KRW -1,35 % Intraday Chart für NEXTURNBIOSCIENCE Co., Ltd. +0,62 % -27,08 %
21.03. NEXTURNBIOSCIENCE Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 NEXTURNBIOSCIENCE Co, Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Mirae Corporation announced that it has received KRW 2.6 billion in funding from NEXTURNBIOSCIENCE Co., Ltd., UA Co.,Ltd
Mirae Corporation announced that it has received KRW 10 billion in funding from NEXTURNBIOSCIENCE Co., Ltd.
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
NexturnBioScience Plans 1 Billion Won Capital Raise through Stock Offering; Shares Jump 4%
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 5.9999959 billion in funding
NEXTURNBIOSCIENCE Co., Ltd. completed the acquisition of 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd.
Mirae Corporation announced that it expects to receive KRW 5 billion in funding from NEXTURNBIOSCIENCE Co., Ltd., UA Co.,Ltd
Mirae Corporation announced that it expects to receive KRW 15 billion in funding from NEXTURNBIOSCIENCE Co., Ltd.
Mirae Corporation announced that it expects to receive KRW 15 billion in funding from NEXTURNBIOSCIENCE Co., Ltd.
NEXTURNBIOSCIENCE Co., Ltd. agreed to acquire a 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd.
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NEXTURNBIOSCIENCE Co., Ltd. cancelled the transaction announced on March 31, 2022
NEXTURNBIOSCIENCE Co., Ltd.(KOSDAQ:A089140) dropped from S&P Global BMI Index
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A089140 Aktie
  4. Nachrichten NEXTURNBIOSCIENCE Co., Ltd.
  5. Andere Sprachen